−0.70HKD
−1.14 BHKD
6.86 BHKD
1.42 B
About INNOVENT BIOLOGICS INC
Sector
CEO
De Chao Yu
Headquarters
Suzhou
Website
Employees (FY)
4.87 K
Founded
2011
ISIN
KYG4818G1010
FIGI
BBG00M8832B5
Innovent Biologics, Inc. is a biopharmaceutical company, which engages in the developing and commercializes drugs. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1801 is 33.20 HKD — it has decreased by 1.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange INNOVENT BIOLOGICS INC stocks are traded under the ticker 1801.
INNOVENT BIOLOGICS INC is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
1801 stock is 4.33% volatile and has beta coefficient of 1.49. Check out the list of the most volatile stocks — is INNOVENT BIOLOGICS INC there?
One year price forecast for INNOVENT BIOLOGICS INC has a max estimate of 77.00 HKD and a min estimate of 36.90 HKD.
1801 earnings for the last quarter are −0.10 HKD per share, whereas the estimation was −0.78 HKD resulting in a 87.50% surprise. The estimated earnings for the next quarter are −0.55 HKD per share. See more details about INNOVENT BIOLOGICS INC earnings.
INNOVENT BIOLOGICS INC revenue for the last quarter amounts to 2.92 B HKD despite the estimated figure of 2.82 B HKD. In the next quarter revenue is expected to reach 3.76 B HKD.
Yes, you can track INNOVENT BIOLOGICS INC financials in yearly and quarterly reports right on TradingView.
1801 stock has fallen by 12.05% compared to the previous week, the month change is a 14.65% fall, over the last year INNOVENT BIOLOGICS INC has showed a 17.00% decrease.
1801 net income for the last quarter is −960.16 M HKD, while the quarter before that showed −157.37 M HKD of net income which accounts for −510.13% change. Track more INNOVENT BIOLOGICS INC financial stats to get the full picture.
Today INNOVENT BIOLOGICS INC has the market capitalization of 54.68 B, it has decreased by 3.04% over the last week.
No, 1801 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1801 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOVENT BIOLOGICS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 4.87 K employees. See our rating of the largest employees — is INNOVENT BIOLOGICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOVENT BIOLOGICS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOVENT BIOLOGICS INC stock shows the sell signal. See more of INNOVENT BIOLOGICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on INNOVENT BIOLOGICS INC future price: according to them, 1801 price has a max estimate of 77.01 HKD and a min estimate of 36.88 HKD. Read a more detailed INNOVENT BIOLOGICS INC forecast: see what analysts think of INNOVENT BIOLOGICS INC and suggest that you do with its stocks.